Summary
The FDA is forecasting a cooperative agreement opportunity (U2F mechanism) to support infrastructure development and maintenance for state manufactured food regulatory programs. The program uses a Flexible Funding Model, meaning recipients may have discretion in how allocated funds are applied across eligible activities. Clinical trials are explicitly not allowed under this award. This is a federal grant/cooperative agreement rather than a traditional procurement contract, aimed at strengthening state-level food safety regulatory capacity.
